TuHURA Biosciences Reports Q2 2026 Financial Results

What Happened

• On August 14, 2026, TuHURA Biosciences, Inc. (HURA) filed a Form 8‑K to furnish a press release that reports the company's financial results for the three months ended June 30, 2026 and provides a corporate update. The press release is attached to the 8‑K as Exhibit 99.1. The report and exhibit are being furnished (not “filed”) under the securities laws. The filing was signed by Chief Financial Officer Dan Dearborn.

Key Details

• Filing date: August 14, 2026.
• Reporting period: quarter ended June 30, 2026 (Q2 2026).
• Press release attached as Exhibit 99.1 contains the reported quarterly results and corporate update.
• Disclosure status: information is furnished and expressly not deemed “filed” or incorporated by reference except where specifically stated.

Why It Matters

• Retail investors should read the attached press release for the company’s reported earnings, revenue, cash position, guidance (if provided), and details of the corporate update — these items can affect near‑term stock performance and investor outlook.
• The “furnished, not filed” designation is a legal detail that limits automatic incorporation of the release into future SEC filings; it does not change the substance of the reported quarterly results.